- Report
- September 2022
- 76 Pages
Global
From €3498EUR$3,950USD£3,023GBP
- Report
- September 2022
- 30 Pages
Global
From €2435EUR$2,750USD£2,104GBP
- Report
- September 2022
- 30 Pages
Global
From €2435EUR$2,750USD£2,104GBP
- Report
- December 2023
- 168 Pages
Global
From €4383EUR$4,949USD£3,787GBP
- Report
- January 2025
- 250 Pages
Global
From €4427EUR$4,999USD£3,825GBP
- Report
- April 2023
- 160 Pages
Global
From €4383EUR$4,949USD£3,787GBP
- Report
- May 2024
- 135 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- May 2024
- 139 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- May 2024
- 136 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- February 2024
- 130 Pages
Global
From €4206EUR$4,750USD£3,635GBP
- Report
- February 2024
- 73 Pages
Middle East, Europe, Africa Middle East, Europe, Africa
From €4206EUR$4,750USD£3,635GBP
- Report
- February 2024
- 112 Pages
Global
From €4206EUR$4,750USD£3,635GBP
- Report
- August 2024
- 173 Pages
Global
From €2214EUR$2,500USD£1,913GBP
- Report
- April 2025
- 218 Pages
Global
From €2214EUR$2,500USD£1,913GBP
- Report
- January 2025
- 192 Pages
Global
From €2214EUR$2,500USD£1,913GBP
- Report
- January 2025
- 200 Pages
Global
From €4423EUR$4,995USD£3,822GBP
- Report
- September 2023
- 220 Pages
Global
€3188EUR$3,600USD£2,755GBP
- Report
- November 2023
- 140 Pages
Global
From €3941EUR$4,450USD£3,405GBP
- Report
- June 2024
- 228 Pages
Global
From €3188EUR$3,600USD£2,755GBP
- Report
- June 2024
- 101 Pages
Asia Pacific
From €1328EUR$1,500USD£1,148GBP

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive.
The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more